List of Studies ( Metabolite:N-Acetyl-leucyl-leucine)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002760 | AN004484 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004488 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004489 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST003084 | AN005042 | Metabolic changes in embryonic CSF (Part 6) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003085 | AN005044 | Metabolome changes in embryonic CSF (Part 7) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
| ST001658 | AN002706 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | Peak area |
| ST003111 | AN005094 | Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression, investigated with targeted metabolomics in Tam-Cre;Pkd1ΔC/flox mouse model kidneys. | Kidney | Mouse | Kidney disease | San Raffaele University | Peak Area |
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | peak height |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST001241 | AN002062 | Global Metabolic Analysis Trisomy 21 - Cohort 3, Plasma | Blood | Human | Down syndrome | University of Colorado, Denver | Relative Abundance |
